Treating the invisible: Subclinical actinic keratosis detected by imiquimod

Treating the invisible: Subclinical actinic keratosis detected by imiquimod

Abstract Background Skin in UV‐exposed areas may develop UV‐induced actinic damage in DNA sequences leading to proliferation of keratinocyte carcinoma, a type of non‐melanoma skin cancer. Actinic keratosis (AK) represents early‐stage in situ squamous cell carcinoma. It develops from the basal cell l...

Full description

Bibliographic Details
Main Authors: Daisy Kopera, Joachim Torrano, H. Peter Soyer
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:JEADV Clinical Practice
Subjects:
actinic keratosis
immunomodulatory
subclinical
treatment
Online Access:https://doi.org/10.1002/jvc2.216

Internet

https://doi.org/10.1002/jvc2.216

Similar Items